North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 746 Aug 1 – Oct 29, 2026
- Disclosed funding
- $112.3B 594 disclosed amounts
- Median round
- $25M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| EM Elio MortgageCompany profile Operates a mortgage brokerage using AI to handle loan-origination administration while loan officers advise borrowers. Operates a mortgage brokerage using AI to handle loan-origination administration while loan officers advise borrowers. | $5.1M | Pre-seed | Fintech | United States | Investors | |
| K KahuaCompany profile Provides enterprise software that connects planning, construction and operations across complex capital programmes. Provides enterprise software that connects planning, construction and operations across complex capital programmes. | Undisclosed | Minority growth investmentGrowth | Enterprise software | United States | Investors | |
| HM Hertha MetalsCompany profile Develops a continuous process for producing iron and steel from different ore grades using natural gas or hydrogen. Develops a continuous process for producing iron and steel from different ore grades using natural gas or hydrogen. | $133.7M | Series A | Industrial tech | United States | Investors | |
 JeevesCompany profile Jeeves provides a financial platform for global businesses, combining corporate cards, cross-border payments, expense controls and treasury tools. Jeeves provides a financial platform for global businesses, combining corporate cards, cross-border payments, expense controls and treasury tools. | $110M | Series C-1Series C+ | Fintech | United States | Investors | |
| a ai3BioCompany profile ai3Bio develops therapies designed to remove disease-causing Th17 immune cells, using antibody and lipid-nanoparticle platforms to address autoimmune disease. ai3Bio develops therapies designed to remove disease-causing Th17 immune cells, using antibody and lipid-nanoparticle platforms to address autoimmune disease. | $48M | Series A | Biotech | United States | Investors | |
| R RemoteThreatCompany profile RemoteThreat provides an offensive cyber-operations platform for enterprise red teams, government mission teams and vetted defence partners. RemoteThreat provides an offensive cyber-operations platform for enterprise red teams, government mission teams and vetted defence partners. | $7M | Pre-seed | Cybersecurity | United States | Investors | |
 RecoCompany profile Cybersecurity software that helps security teams discover, govern and secure SaaS applications, identities and AI agents. Cybersecurity software that helps security teams discover, govern and secure SaaS applications, identities and AI agents. | $55M | Series B extensionSeries B | Cybersecurity | United States | Investors | |
| f flowscopeCompany profile flowscope automates enterprise work by connecting business processes and using AI to reduce repetitive operational tasks. flowscope automates enterprise work by connecting business processes and using AI to reduce repetitive operational tasks. | $3.8M | Seed | Business services | United States | Investors | |
 Efficient ComputerCompany profile Efficient Computer develops general-purpose data-flow processors and software tools for computing and AI systems. Efficient Computer develops general-purpose data-flow processors and software tools for computing and AI systems. | >$97M | Series B financing agreementsSeries B | Hardware | United States | Investors | |
 EliseAICompany profile Agentic AI software for housing operators and healthcare providers that automates customer conversations and operational workflows. Agentic AI software for housing operators and healthcare providers that automates customer conversations and operational workflows. | $350M | Growth financingUndisclosed | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Aug 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
56rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
43rounds16led - 3Sequoia Capital
Hex, Warhound, Whop
25rounds7led - 4Khosla Ventures
Arda Industries, Tolan
25rounds6led - 5General Catalyst
Hyperbolic, Re:Build, Provision Labs
24rounds7led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.